Warning: The NCBI web site requires JavaScript to function. more...
National Cancer Center, Goyang, Republic of Korea. bachism@empal.com
A case-control study in the Republic of Korea evaluated the protective effectiveness of the hantavirus vaccine. Point estimates showed increasing effectiveness with increasing numbers of doses received: 25% for one dose, 46% for two doses, and 75% for three doses. All 95% confidence intervals overlapped zero; therefore, the findings could be due to chance.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on